Selective anticancer effects of 3',5'-dioctanoyl-5-fluoro-2'-deoxyuridine, a lipophilic prodrug of 5-fluoro-2'-deoxyuridine, dissolved in an oily lymphographic agent on hepatic cancer of rabbits bearing VX-2 tumor.

No abstract is available for this paper.

• Publication year

  1987

• Venue

  Cancer Research

• Publication date

  1987-04-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  PMID 3028618
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Antitumor activity of 3′, 5′-diesters of 5-fluoro-2′-deoxyuridine against murine leukemia L1210 cells

  2004cited by this paper
• PREPARATION AND EVALUATION OF W/O TYPE AND W/O/W TYPE EMULSIONS CONTAINING AN ANTICANCER DRUG

  1986cited by this paper
• Specificity of esterases and structure of prodrug esters. II. Hydrolytic regeneration behavior of 5-fluoro-2'-deoxyuridine (FUdR) from 3',5'-diesters of FUdR with rat tissue homogenates and plasma in relation to their antitumor activity.

  1985cited by this paper
• [Experimental study of hepatic arterial embolization therapy by various formulations of the anticancer agent lipiodol].

  1985cited by this paper
• Activity of esterase in the hydrolysis of 3',5'-diesters of 5-fluoro-2'-deoxyuridine in relation to the structure of the diester prodrugs.

  1985cited by this paper
• Selective targeting of anti‐cancer drug and simultaneous image enhancement in solid tumors by arterially administered lipid contrast medium

  1984cited by this paper
• Use of oily contrast medium for selective drug targeting to tumor: enhanced therapeutic effect and X-ray image.

  1984cited by this paper
• Selective effects of lipiodolized antitumor agents

  1984cited by this paper
• Effect of arterial administration of high-molecular-weight anticancer agent SMANCS with lipid lymphographic agent on hepatoma: a preliminary report.

  1983cited by this paper
• Hepatic intraarterial chemotherapy--current status and future prospects--"If you have a short sword, take a step forward".

  1983cited by this paper
• Hepatic intraarterial chemotherapy--current status and future prospects--"If you have a short sword, take a step forward".

  1983cited by this paper
• A clinical-pharmacological evaluation of hepatic arterial infusions of 5-fluoro-2'-deoxyuridine and 5-fluorouracil.

  1978cited by this paper
• 3',5'-diesters of 5-fluoro-2'-deoxyuridine: synthesis and biological activity.

  1965cited by this paper

• Mechanism of Action, Pharmacokinetics, Efficacy, and Safety of Transarterial Therapies Using Ethiodized Oil: Preclinical Review in Liver Cancer Models.

  2017cites this paper
• Effect of sodium thiosulfate on cisplatin removal after intra-arterial embolization with a lipiodol-platinum suspension for hepatocellular carcinoma

  2010cites this paper
• Distribution of Lipiodol in hepatocellular carcinoma.

  2008cites this paper
• Pharmacokinetic and Pharmacodynamic Advantages of Pirarubicin over Adriamycin after Intraarterial Hepatic Administration in the Rabbit VX 2 T \ imor Model 1

  2006cites this paper
• A New Class of 5-Fluoro-2′-deoxyuridine Prodrugs Conjugated with a Tumor-Homing Cyclic Peptide CNGRC by Ester Linkers: Synthesis, Reactivity, and Tumor-Cell–Selective Cytotoxicity

  2005cites this paper
• From physical pharmacy to clinical pharmacology.

  2005cites this paper
• Floxuridine Amino Acid Ester Prodrugs: Enhancing Caco-2 Permeability and Resistance to Glycosidic Bond Metabolism

  2005cites this paper
• Amino Acid Ester Prodrugs of Floxuridine: Synthesis and Effects of Structure, Stereochemistry, and Site of Esterification on the Rate of Hydrolysis

  2003cites this paper
• Long-term follow-up of hepatic arterial chemoembolization with cisplatin suspended in iodized oil for hepatocellular carcinoma.

  2003cites this paper
• Survival and local recurrence rates of hepatocellular carcinoma patients treated by transarterial chemolipiodolization with and without embolization.

  2002cites this paper
• Enhanced brain targeting by synthesis of 3',5'-dioctanoyl-5-fluoro-2'-deoxyuridine and incorporation into solid lipid nanoparticles.

  2002cites this paper
• In vitro cytotoxicity of cis[((1R,2R)-1,2-cyclohexanediamine-N,N')bis(myristato)] platinum(II) suspended in lipiodol in rat hepatoma AH-109A cells and human tumor cell lines.

  2000cites this paper
• Antitumor effects of a novel lipophilic platinum complex (SM-11355) against a slowly-growing rat hepatic tumor after intra-hepatic arterial administration.

  2000cites this paper
• Systemic administration of a synthetic lipid A derivative, DT-5461a, reduces tumor blood flow through endogenous TNF production in hepatic cancer model of VX2 carcinoma in rabbits.

  1996cites this paper
• Antitumor effects of intraarterial infusion of tumor necrosis factor/lipiodol emulsion on hepatic tumor in rabbits.

  1995cites this paper
• Effects of delta(7)-prostaglandin a(1) methyl-ester on human ovarian-cancer cell-growth in-vitro and in nude-mice.

  1994cites this paper
• Iodized oil in the treatment of hepatocellular carcinoma

  1994cites this paper
• In-vitro stability and cytostatic activity of liposomal formulations of 5-fluoro-2'-deoxyuridine and its diacylated derivatives.

  1993cites this paper
• Selective accumulation and tumoricidal effect of cisplatin suspended in viscous ethyl oleate on hepatic cancers in animals after intraarterial infusion.

  1993cites this paper
• Pharmacokinetic and pharmacodynamic advantages of pirarubicin over adriamycin after intraarterial hepatic administration in the rabbit VX2 tumor model.

  1993cites this paper
• Evaluation of oil-soluble FUdR ester for transcatheter arterial treatment of hepatomas.

  1992cites this paper
• Anticancer effects of free polyunsaturated fatty acids in an oily lymphographic agent following intrahepatic arterial administration to a rabbit bearing VX-2 tumor.

  1992cites this paper
• Distribution of Lipiodol and evidence for tumor necrosis in hepatocellular carcinoma.

  1992cites this paper
• Preparation of [131I]lipiodol as a hepatoma therapeutic agent.

  1992cites this paper
• In vitro release, pharmacokinetic and tissue distribution studies of doxorubicin hydrochloride (Adriamycin HCl) encapsulated in lipiodolized w/o emulsions and w/o/w multiple emulsions.

  1992cites this paper
• In vivo distribution and antitumour activity of liposomal 3',5'-O-dipalmitoyl-5-fluoro-2'-deoxyuridine.

  1992cites this paper
• [Animal models for hepatic metastases].

  1991cites this paper
• Angiotensin alteration of drug uptake in an experimental model of hepatic metastases.

  1991cites this paper
• Release characteristics of a free polyunsaturated fatty acid from an oily lymphographic agent.

  1990cites this paper
• Prognostic Factors in Liver Metastases after Transcatheter Arterial Embolization or Arterial Infusion

  1990cites this paper
• Lipiodol drug targeting in the treatment of primary hepatocellular carcinoma.

  1990cites this paper
• Liposome-Incorporated 3′,5′-O-Dipalmitoyl-5 -Fluoro-2′-Deoxyuridine as a Slow-Release Anti-Tumor Drug Depot in Rat Liver Macrophages

  1990cites this paper
• Efficacy of two‐route chemotherapy using cis‐diamminedichloroplatinum(II) and its antidote, sodium thiosulfate, in combination with angiotensin II for rat liver tumor

  1989cites this paper
• Tissue Distribution of Cisplatin After Hepatic Arterial Injection of a Cisplatin–Lipiodol Suspension Containing Phosphatidylcholine to Rabbits Carrying VX-2 Hepatic Carcinoma

  1989cites this paper
• Intraarterial infusion of 5‐fluoro‐2‐deoxyuridine‐C8 dissolved in a lymphographic agent in malignant liver tumors. A preliminary report

  1989cites this paper
• Hydrolysis of 3',5'-dioctanoyl-5-fluoro-2'-deoxyuridine (FdUrd-C8) in rabbit and human plasma and its release from oily solution.

  1989cites this paper
• Delivery of anticancer drugs.

  1989cites this paper
• Hepatic artery versus portal vein and systemic infusion of fluorodeoxyuridine of rabbit VX-2 hepatic implants.

  1989cites this paper
• The Cyclic Dimer of 5-fluoro-2'-deoxyuridylic Acid - a Potent Anticancer Agent

  1989cites this paper
• Hepatic arterial injection chemotherapy with cisplatin suspended in an oily lymphographic agent for hepatocellular carcinoma

  1989cites this paper
• Selective accumulation of 3',5'-dioctanoyl-5-fluoro-2'-deoxyuridine (FdUrd-C8) and sustained release of its active metabolites in VX-2 rabbit hepatoma following intraarterial administration of FdUrd-C8 solution in Lipiodol.

  1988cites this paper
• リピオドール中シスプラチン懸濁液(LPS)による肝細胞癌の動注化学療法

  1988cites this paper
• Nonenzymatic and Enzymatic Hydrolysis of 5-Fluoro-2′-deoxyuridine (FUdR) Esters

  1988cites this paper
• アクラルビシン含有ポリ-β-ヒドロキシ酪酸マイクロスフェアの調製と肝動注による評価

  1987cites this paper